Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Genetics

Understanding Diastrophic Dysplasia: A Guide for Parents

At a Glance

Diastrophic dysplasia (DTD) is a rare genetic condition affecting cartilage and bone growth due to variations in the SLC26A2 gene. While it requires orthopedic and respiratory management, DTD does not affect intelligence, and most individuals live full, healthy lives well into adulthood.

Receiving a diagnosis of Diastrophic Dysplasia (DTD) can feel like entering an unfamiliar world. While this condition is rare, it is a well-understood genetic condition with a clear biological cause [1]. Understanding how DTD works and what it means for your child’s future can help replace uncertainty with a focused plan for their care.

The Biology of Sulfate and Cartilage

The primary cause of DTD is a change in the SLC26A2 gene [2]. This gene is responsible for creating a “transporter” protein that acts like a gatekeeper for cells [1]. Its job is to move sulfate—a vital mineral—from the bloodstream into the cells that build cartilage (chondrocytes) [1][3].

In children with DTD, this transporter does not function correctly, leading to several biological changes:

  • Low Sulfate Levels: Because the “gate” isn’t working, not enough sulfate enters the cartilage-building cells [1][2].
  • Undersulfated Proteoglycans: Sulfate is needed to “finish” the building blocks of cartilage called proteoglycans. Without enough sulfate, these blocks are incomplete [1][3].
  • Weakened Scaffolding: Cartilage acts as the scaffolding for growing bones. In DTD, the “undersulfated” scaffolding is less stable, which leads to the characteristic physical features of the condition, such as shorter limbs and unique joint positions [1][4].

Why the Finnish Connection Matters

You may hear doctors mention a “Finnish founder mutation” [5]. In Finland, DTD is more common because of a specific genetic variant (c.727-1G>C) passed down through generations [5]. While DTD occurs in all populations worldwide, the extensive research conducted in Finland has provided the global medical community with a deep understanding of how the condition progresses and how best to manage it [6].

Essential Reassurance for Parents

When a child is diagnosed with a skeletal dysplasia, parents often have two immediate concerns: intelligence and life expectancy.

  • Cognitive Development: It is important to know that DTD does not affect brain development or intelligence [7]. Children with DTD have the same range of cognitive potential, personality, and intellectual capability as their peers. They are expected to attend mainstream schools and pursue their own unique interests and careers [8].
  • Long-Term Outlook: While DTD presents physical challenges that require lifelong management, most individuals live full lives into adulthood [9][8]. There are documented cases of individuals living well into their 40s and beyond, pursuing higher education, and starting families of their own [9][10].

Navigating the Early Days and the NICU

The most critical period for a child with DTD is infancy, where the focus is on physical stability and breathing.

  • NICU Expectations: Many infants with DTD will spend time in the Neonatal Intensive Care Unit (NICU). This allows specialists to closely monitor their breathing, assess their spine, and help with initial feeding challenges. Knowing what monitors and specialists will be buzzing around the bassinet can help you feel more prepared.
  • Cervical Kyphosis: This is a specific curve in the neck bones that can occur in infants with DTD [11]. It is essential to have your child’s spine screened early by a specialist to ensure the spinal cord is protected [11]. Until the spine is cleared, you will receive specific instructions on how to handle your baby safely.
  • Respiratory Health: Some infants may have narrower airways (a condition called tracheomalacia), which requires monitoring to ensure they are breathing comfortably [7].

Your child’s journey will be unique, but it is a path that many families have walked before. With a multidisciplinary team of specialists—including genetics, orthopedics, and physical therapy—your child can thrive while managing the physical aspects of DTD [8].

Common questions in this guide

Does diastrophic dysplasia affect a child's intelligence?
No, diastrophic dysplasia does not affect brain development or cognitive ability. Children with DTD have the same intelligence and potential as their peers and typically attend mainstream schools.
What is the life expectancy for someone with diastrophic dysplasia?
Most individuals with diastrophic dysplasia live full, active lives into adulthood. While the condition requires lifelong management of physical symptoms, many people with DTD pursue higher education, have careers, and start families.
What causes diastrophic dysplasia?
The condition is caused by a variation in the SLC26A2 gene. This gene normally helps transport sulfate into cells to build strong cartilage, but in DTD, this process doesn't work correctly, leading to weakened bone scaffolding and shorter limbs.
Why do babies with diastrophic dysplasia often stay in the NICU?
Infants with DTD often spend time in the NICU so specialists can closely monitor their breathing, assess their spine for dangerous curves, and assist with any early feeding challenges.
What is cervical kyphosis and why is it monitored in infants with DTD?
Cervical kyphosis is a specific curve in the neck bones that can occur in infants with DTD. Early screening by a specialist is crucial to ensure the spinal cord is protected before handling the baby normally.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can you explain the specific findings on my child's cervical spine X-ray and how we will monitor for stability?
  2. 2.What specialized respiratory screenings (like a sleep study) do you recommend for infants with DTD?
  3. 3.Based on my child's specific genetic variants, what should we expect regarding their growth and mobility milestones?
  4. 4.Are there local or national specialists you recommend who have experience managing DTD specifically?
  5. 5.Can you connect us with a genetic counselor to discuss the SLC26A2 mutation in more detail?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine.

    Paganini C, Gramegna Tota C, Monti L, et al.

    Biochemical pharmacology 2021; (185()):114452 doi:10.1016/j.bcp.2021.114452.

    PMID: 33545117
  2. 2

    N-acetylcysteine treatment ameliorates the skeletal phenotype of a mouse model of diastrophic dysplasia.

    Monti L, Paganini C, Lecci S, et al.

    Human molecular genetics 2015; (24(19)):5570-80 doi:10.1093/hmg/ddv289.

    PMID: 26206888
  3. 3

    Identification of potential non-invasive biomarkers in diastrophic dysplasia.

    Paganini C, Carroll RS, Gramegna Tota C, et al.

    Bone 2023; (175()):116838 doi:10.1016/j.bone.2023.116838.

    PMID: 37454964
  4. 4

    Suppressing UPR-dependent overactivation of FGFR3 signaling ameliorates SLC26A2-deficient chondrodysplasias.

    Zheng C, Lin X, Xu X, et al.

    EBioMedicine 2019; (40()):695-709 doi:10.1016/j.ebiom.2019.01.010.

    PMID: 30685387
  5. 5

    SLC26A2/DTDST Spectrum: A Cohort of 12 Patients Associated with a Comprehensive Review of the Genotype-Phenotype Correlation.

    Silveira C, da Costa Silveira K, Lacarrubba-Flores MD, et al.

    Molecular syndromology 2023; (13(6)):485-495 doi:10.1159/000525020.

    PMID: 36660027
  6. 6

    Genetic spectrum of prenatally diagnosed skeletal dysplasias in a Finnish patient cohort.

    Rajala K, Kasanen E, Toiviainen-Salo S, et al.

    Prenatal diagnosis 2022; (42(12)):1525-1537 doi:10.1002/pd.6186.

    PMID: 35611473
  7. 7

    SLC26A2-Associated Diastrophic Dysplasia and rMED-Clinical Features in Affected Finnish Children and Review of the Literature.

    Härkönen H, Loid P, Mäkitie O

    Genes 2021; (12(5)) doi:10.3390/genes12050714.

    PMID: 34064542
  8. 8

    Management of a Parturient with Diastrophic Dysplasia.

    Lagoy JS, Kofford ND, Gosselin BJ, et al.

    A & A case reports 2015; (5(1)):6-8 doi:10.1213/XAA.0000000000000162.

    PMID: 26125691
  9. 9

    SLC26A2 Related Diastrophic Dysplasia in 42-Years Ukrainian Women.

    Bondarenko M, Haiboniuk I, Solovei I, et al.

    Balkan journal of medical genetics : BJMG 2023; (25(2)):83-90 doi:10.2478/bjmg-2022-0018.

    PMID: 37265969
  10. 10

    Esophageal stenosis in an adult Mexican patient with diastrophic dysplasia: Case report.

    Kimball TN, Rivero-García P, Pérez González B, Reza-Albarrán AA

    Clinical case reports 2023; (11(10)):e8028 doi:10.1002/ccr3.8028.

    PMID: 37881199
  11. 11

    Cervical spine surgery in patients with diastrophic dysplasia: Case report with long-term follow-up.

    Jasiewicz B, Potaczek T, Duda S, Tęsiorowski M

    Journal of craniovertebral junction & spine 2015; (6(4)):216-8 doi:10.4103/0974-8237.167886.

    PMID: 26692703

This page provides educational information about diastrophic dysplasia for parents and caregivers. It does not replace professional medical advice from your child's geneticist, orthopedist, or pediatrician.

Get notified when new evidence is published on Diastrophic dysplasia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.